Imidapril hydrochloride in essential hypertension : a double-blind comparative study using enalapril maleate as a control

Objective:To assess the value of using imidapril hydrochloride (ACE/TA-6366), a long-acting angiotensin converting enzyme (ACE) inhibitor developed in Japan, to treat patients with essential hypertension.Patients and methods:A double-blind, comparative, phase III study was carried out using enalapri